Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Gronchi

Showing results (331-340 of 486) with videos related to

Pageof 49
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 12, 2024
Preoperative nutritional support to tackle morbidity in multivisceral resection for retroperitoneal sarcoma. Early outcomes from a novel nutritional prehabilitation program in a prospective cohortMarco Baia, Claudia Zanframundo, Silva Ljevar, et al.
Annals of Surgical Oncology|October 11, 2014
Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resectionAlessandro Gronchi, Rosalba Miceli, Marc Antoine Allard, et al.
Disease Models & Mechanisms|May 9, 2023
Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograftValentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Annals of Surgery|December 6, 2019
The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient DataMilea J M Timbergen, Chiara Colombo, Michel Renckens, et al.
Histopathology|January 11, 2023
Datasets for reporting of soft-tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Angelo Paolo Dei Tos, Fleur Webster, Abbas Agaimy, et al.
The American Journal of Surgical Pathology|October 15, 2011
Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variablesSabrina Rossi, Rosalba Miceli, Luca Messerini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus IfosfamideElena Palassini, Stefano Ferrari, Paolo Verderio, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2023
Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical studySilvia Stacchiotti, Giacomo Giulio Baldi, Anna Maria Frezza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 TrialsOlivier Mir, Nathan Touati, Michela Lia, et al.
Cancer|September 17, 2004
Imatinib mesylate in chordomaPaolo G Casali, Antonella Messina, Silvia Stacchiotti, et al.
Pageof 49

Showing results (331-340 of 486) with videos related to

Sort By:
Pageof 49
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 12, 2024
Preoperative nutritional support to tackle morbidity in multivisceral resection for retroperitoneal sarcoma. Early outcomes from a novel nutritional prehabilitation program in a prospective cohortMarco Baia, Claudia Zanframundo, Silva Ljevar, et al.
Annals of Surgical Oncology|October 11, 2014
Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resectionAlessandro Gronchi, Rosalba Miceli, Marc Antoine Allard, et al.
Disease Models & Mechanisms|May 9, 2023
Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograftValentina Zuco, Sandro Pasquali, Monica Tortoreto, et al.
Annals of Surgery|December 6, 2019
The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient DataMilea J M Timbergen, Chiara Colombo, Michel Renckens, et al.
Histopathology|January 11, 2023
Datasets for reporting of soft-tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Angelo Paolo Dei Tos, Fleur Webster, Abbas Agaimy, et al.
The American Journal of Surgical Pathology|October 15, 2011
Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variablesSabrina Rossi, Rosalba Miceli, Luca Messerini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus IfosfamideElena Palassini, Stefano Ferrari, Paolo Verderio, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2023
Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical studySilvia Stacchiotti, Giacomo Giulio Baldi, Anna Maria Frezza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 TrialsOlivier Mir, Nathan Touati, Michela Lia, et al.
Cancer|September 17, 2004
Imatinib mesylate in chordomaPaolo G Casali, Antonella Messina, Silvia Stacchiotti, et al.
Pageof 49